Analyzing data in the 2024 Springfield fire report
SPRINGFIELD, Mo. — The Springfield Fire Department (SFD) has released its 2024 annual report, noting the department has strengthened its emergency preparedness and response by enhancing operational capabilities, expanding public safety initiatives, and reinforcing community partnerships.
One significant achievement in 2024 was the completion and opening of the newly reconstructed Fire Station 7. This state-of-the-art facility was made possible by voter-approved funding and was designed with firefighter health and safety in mind, improving efficiency and emergency response times, according to a news release.
The annual report cites several facts from SFD's year in 2024:
40,424 instructional hours were delivered to 634 students
185 leave-behind naloxone kits (which can treat narcotic overdoses in an emergency situation) were distributed by firefighters in 2024
SFD firefighters visited 5,440 homes and installed 1,436 smoke alarms
34 structure fire investigations led to felony charges in 11 fires
Only 153 structure fires and 41 vacant structure fires were reported.
Compared to previous year's data, there was a decrease in yearly opioid incidents. The year of 2024 saw 122 incidents, compared to a peak of 463 incidents recorded in 2021.
However, fire calls were up when compared; 940 in 2024, and 886 in 2023.
'Community Risk Reduction remains a cornerstone of our mission,' said Fire Chief David Pennington in the release. 'Through our Project RED Zone initiative, we engaged thousands of households, installed hundreds of smoke alarms and provided critical fire safety education.'
Pennington said the SFD expanded its outreach efforts with fire and life safety programs, community CPR and AED training, and senior fire safety initiatives, ensuring that residents of all ages have the knowledge and tools to prevent fires and emergencies.
'Our continued naloxone distribution program, with leave-behind kits, played a vital role in public health and harm reduction, increasing bystander intervention and saving lives in opioid overdose incidents,' Pennington said.
Read the full SFD 2024 annual report here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Highmark Walk for a Healthy Community takes place at Penn State Behrend
The public was invited to step in to support their favorite non-profit organization. The Highmark Walk for a Healthy Community took place at Penn State Behrend Saturday morning. Ten local non-profits were in attendance, raising money for their own individual missions. Tickets now available Erie Zoo's centennial Mane Event Participants walked either a 5K or one mile and were able to take part in family-friendly activities as well. 'We have the YMCA doing line dancing, we have the walks and all the help, and I love seeing the dogs and children and all the fun,' said Michelle Smiley, the director of the walk. 'We have a scavenger hunt for them, it's just, we have a wonderful day of engagement with the community, it's beautiful.' Smiley said they raised almost $35,000 this year. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
The Coastal Health District offering free HIV testing
SAVANNAH, Ga. (WSAV) – The Coastal Health District HIV Prevention Program is partnering with Walgreens to hold free HIV testing events to commemorate National HIV Testing Day (NHTD). This year's NHTD events will be held on Friday, June 27, at these Walgreens locations in Chatham and Glynn counties: 2109 E. Victory Drive, Savannah: 10 a.m. – 5 p.m. 11509 Abercorn Street, Savannah: 10 a.m. – 3 p.m. 700 E. DeRenne Avenue, Savannah: 10 a.m. – 5 p.m. 4210 Augusta Road, Garden City: 10 a.m. – 3 p.m. 4575 Altama Avenue, Brunswick: 10 a.m. – 3 p.m. According to the Coastal Health District, Georgia has some of the highest HIV rates in the country. Many people living with HIV may not be aware of their status. There are many effective ways to prevent HIV or, if you are infected, to treat HIV so you can live a healthy and full life. But the first step is to know your status. As a reminder, HIV testing is always free by appointment at all health departments in Bryan, Camden, Chatham, Effingham, Glynn, Liberty, Long, and McIntosh counties. Free self-test kits are also available and can be used at home. For more information on the Coastal Health District, click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
2 hours ago
- Yahoo
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory
We came across a bullish thesis on ClearPoint Neuro, Inc. (CLPT) on M.V. Cunha's Substack. In this article, we will summarize the bulls' thesis on CLPT. ClearPoint Neuro, Inc. (CLPT)'s share was trading at $13.93 as of 6th June. A medical doctor surrounded by advanced technology in the operating room. ClearPoint Neuro is transforming from a surgical tools provider into a critical platform company enabling the next generation of neurological treatments. In the first quarter of 2025, revenue grew 31 percent year-over-year to 8.5 million dollars, led by the rapid adoption of its SmartFrame operating room system, which increased 70 percent and allows hospitals to use ClearPoint technology in standard surgical settings. This expansion seeds a larger installed base and drives high-margin recurring revenue from disposable instruments. The biologics and drug delivery segment generated 4.7 million dollars in revenue, growing 9 percent year-over-year, and is supported by more than 60 active partnerships with gene and cell therapy developers. As these therapies move toward commercial use, ClearPoint's role as the enabling delivery infrastructure could become its most profitable revenue stream, with each procedure generating over 20,000 dollars in high-margin recurring revenue. Meanwhile, the company is intentionally moving away from capital equipment sales, which declined 63 percent, in favor of a subscription-based model that provides predictable recurring revenue. Operating cash burn fell 35 percent in 2024, with expenses rising 29 percent in the latest quarter due to targeted investments in preclinical services, therapy support, and device innovation. ClearPoint closed the quarter with 12.4 million dollars in cash and access to up to 105 million dollars in financing, providing sufficient capital to reach financial breakeven without near-term equity dilution. While risks around execution, partner dependency, and regulatory pacing remain, ClearPoint's embedded position across neurological therapy development offers investors a unique opportunity to benefit from a long-term transformation into the backbone of next-generation brain treatments. Previously, we highlighted a on ClearPoint Neuro from northeasternsvf in January 2025, which emphasized its unique position as the only FDA-cleared, MRI-guided neurosurgical platform enabling precise delivery of CNS gene and cell therapies. That thesis focused on the company's expanding biopharma partnerships, operating room penetration through SmartFrame OR, and its path to profitability via high-margin disposables. ClearPoint Neuro, Inc. (CLPT) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 21 hedge fund portfolios held CLPT at the end of the first quarter which was 13 in the previous quarter. While we acknowledge the risk and potential of CLPT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than CLPT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey.
